Status:
COMPLETED
Specialized Treatment Early in Psychosis (STEP)
Lead Sponsor:
Yale University
Conditions:
Schizophrenia and Disorders With Psychotic Features
Eligibility:
All Genders
16-45 years
Phase:
NA
Brief Summary
The purpose of this study is to understand the effectiveness of a specialized package of phase-specific treatments for individuals in the midst of their first episode of psychosis. The pharmacologic a...
Detailed Description
We propose to conduct a clinical trial for first episode psychosis patients not eligible for CMHC services that will compare randomized access to care at CMHC versus the usual procedure of referral to...
Eligibility Criteria
Inclusion
- Age 16-45
- Meets DSM-IV schizophrenia spectrum psychosis or affective psychosis according to the SCID
- ≤8 weeks of received antipsychotic treatment lifetime at time of referral
- Willing to be treated in New Haven
Exclusion
- Psychosis believed due to substance use (based on the SCID)
- Unable or unwilling to give informed consent
- MR as indicated by receipt of services from Dept of Mental Retardation
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00309452
Start Date
March 1 2006
End Date
August 1 2013
Last Update
February 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Connecticut Mental Health Center
New Haven, Connecticut, United States, 06519